Diet and chemotherapy: a potential new synergy
The CALIMERO study (CALorie restriction with chemo- and IMmunotherapy in ER-negative and HER2-negative early breast cancer – a randomised trial) involves 50 women with triple-negative breast cancer, randomly assigned to two groups. The aim is to determine whether a low-calorie diet enriched with MCT, followed for a few days before and after chemotherapy and immunotherapy, can make the treatment more effective and reduce side effects. Researchers expect that participants following this diet will show a reduction of more than 30% in the tumour marker Ki-67, indicating a slowdown in the growth of cancer cells. An important step towards improving quality of life and offering renewed hope to many patients.
Principal Investigator
Dr. Daniel Egle, Brust Gesundheitszentrum Innsbruck
More info: Frauenklinik Innsbruck
